Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Merck Submits Januvia/Metformin NDA Aiming To Launch First Fixed-Dose DPP-4 Inhibitor

Jul 31 2006

• By Jonathan Block

Related Content

Novartis' Galvus NDA Follows Close On The Heels Of Merck's Januvia

Mar 30 2006

Weighing In On DPP-IV Inhibitors: Galvus, Januvia Both Highlight Weight Profiles

Jun 13 2006

Merck To Submit Januvia/Metformin Combo In 2006

Jun 05 2006

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window